Understanding OUR Cytokine-Based Immunotherapy Candidates Our motivation extends to advancing a robust portfolio of programs targeted at increasing the horizons of cytokine-based immunotherapy, especially for cancers where procedure options remain limited. Utilize the links below to learn extra about our portfolio of cytokine-based immunotherapy candidates. Take a look at https://financefeeds.com/etoro-files-for-u-s-ipo-plans-nasdaq-listing-under-etor/